CE Credit Available Until: February 1, 2016
Access: Virtual Lecture
This activity has been designed to meet the education needs of nurses and social workers involved in the care of patients living with hematologic cancers.
This activity will provide an opportunity for nurses and social workers to expand their knowledge about how clinical trials and genomics influence treatment and prognosis for patients with blood cancers.
After completing this activity, participants should be able to:
- Explain their role in helping patients to enroll in clinical trials and optimize outcomes
- Describe how diversity issues impact enrollment and education about clinical trials
- Identify communication touch points in treating patients in clinical trials
- Explain how genomics research, including cytogenetics and other biomarkers, relates to treatment and prognosis for patients with blood cancer
- Describe communication strategies in educating patients about genomic information
- Describe strategies for addressing ethical issues encountered in patient care
Amy Goodrich, ACNP-BC
Johns Hopkins Kimmel Cancer Center
Donelle Rizzuto, RN, OCN
Clinical Nurse Coordinator
Seattle Cancer Care Alliance
Sponsors and Supporters
This program is supported by The Leukemia & Lymphoma Society.